Mirae Asset Global Investments Co., Ltd. Atri Cure, Inc. Transaction History

Mirae Asset Global Investments Co., Ltd.

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 01, 2024	SELL	$28.21 - $37.78 $28,210 - $37,780	-1,000 Reduced 4.71%	20,237 $615,000
Q4 2023 Jan 24, 2024	BUY	$32.99 - $43.25 $15,967 - $20,933	484 Added 2.33%	21,237 $757,000
Q3 2023 Oct 26, 2023	BUY	$41.12 - $57.73 $21,217 - $29,788	516 Added 2.55%	20,753 $908,000
Q4 2022 Feb 09, 2023	BUY	$33.48 - $47.45 $38,669 - $54,804	1,155 Added 6.05%	20,237 $898,000
Q3 2022 Nov 10, 2022	BUY	$38.25 - $52.62 $221,085 - $304,143	5,780 Added 43.45%	19,082 $746,000
Q2 2022 Jul 26, 2022	BUY	$35.1 - $66.01 $466,900 - $878,065	13,302 New	13,302 $544,000

212

49.7M

12K

7.2K

Ticker ATRC
Exchange NASDAQ
Sector Healthcare
Industry Medical Instruments & Supplies
Shares Outstandng 46,424,700
Market Cap $1.66B
Description
AtriCure, Inc. develops, manufactures, and sells devices for the surgical ablation of cardiac tissue and systems, and intercostal nerves to medical centers in the United States, Europe, Asia, and internationally. The company offers Isolator Synergy Clamps, a single-use disposable radio frequency products; multifunctional pens and linear ablation...

Get notified when there are updates to the investment portfolio of Mirae Asset Global Investments Co., Ltd., based on Form 13F filings with the SEC.

Stay updated on Mirae Asset Global Investments Co., Ltd. with notifications on news.